Inflamax Research

Mississauga, Canada Founded: 2012 • Age: 14 yrs Acquired By Cliantha
CRO focused on early late phase biosimilars research services

About Inflamax Research

Inflamax Research is a company based in Mississauga (Canada) founded in 2012 was acquired by Cliantha in April 2017.. Inflamax Research offers products and services including Early Phase Services, Late Phase Services, Biometrics Services, Lab Services, and Consumer Research. Inflamax Research operates in a competitive market with competitors including Charles River Laboratories, LabCorp, Cytel, Precision Medicine Group and Precision for Medicine, among others.

  • Headquarter Mississauga, Canada
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Cliantha Research
Operational Areas
Healthcare → Healthcare Services & Infrastructure
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Latest Funding Round
  • Investors
  • Employee Count
    Employee Count
  • Acquired by
    Cliantha

    (Apr 21, 2017)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Inflamax Research

Inflamax Research offers a comprehensive portfolio of products and services, including Early Phase Services, Late Phase Services, Biometrics Services, Lab Services, and Consumer Research. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Conducts early stage drug trials and research for pharmaceuticals.

Manages advanced stage trials and data analysis services.

Provides statistical and biometric support for clinical studies.

Offers laboratory testing for respiratory and dermatology research.

Conducts research on consumer products and tobacco-related studies.

Funding Insights of Inflamax Research

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Inflamax Research

Inflamax Research has secured backing from 1 investor. Prominent investors backing the company include Cliantha. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Investor Description Founded Year Domain Location
Diversified clinical research services are offered globally.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Inflamax Research

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Inflamax Research

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Inflamax Research Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Inflamax Research

Inflamax Research operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Charles River Laboratories, LabCorp, Cytel, Precision Medicine Group and Precision for Medicine, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Provider of drug discovery and preclinical development services
domain founded_year HQ Location
Provider of laboratory tests for physicians
domain founded_year HQ Location
Data analysis and statistical solutions are provided for life sciences.
domain founded_year HQ Location
Provider of clinical research, development, and commercialization services for life sciences
domain founded_year HQ Location
Company offering specialised R&D and clinical development services for the development of precision medicine based drugs and devices
domain founded_year HQ Location
Contract research organisation offering drug discovery, preclinical and clinical development services
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Inflamax Research

Frequently Asked Questions about Inflamax Research

When was Inflamax Research founded?

Inflamax Research was founded in 2012.

Where is Inflamax Research located?

Inflamax Research is headquartered in Mississauga, Canada. It is registered at Mississauga, Ontario, Canada.

What does Inflamax Research do?

Inflamax Research offers Early Phase Services, Late Phase Services, Biometrics Services, Lab Services, Consumer Research while focusing on providing healthcare solutions, biopharma outsourcing, cro, and diversified. CRO focused on early late phase biosimilars research services. Delivering reliable solutions, it emphasizes quality, efficiency, and meeting diverse client needs.

Who are the top competitors of Inflamax Research?

Inflamax Research's top competitors include LabCorp, Charles River Laboratories and Cytel.

What products or services does Inflamax Research offer?

Inflamax Research offers Early Phase Services, Late Phase Services, Biometrics Services, Lab Services, and Consumer Research.

Who are Inflamax Research's investors?

Inflamax Research has 1 investor. Key investors include Cliantha.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available